| Literature DB >> 23825556 |
Matthew O Wiens1, Shane Pawluk, Niranjan Kissoon, Elias Kumbakumba, J Mark Ansermino, Joel Singer, Andrew Ndamira, Charles Larson.
Abstract
OBJECTIVES: Mortality following hospital discharge is an important and under-recognized contributor to overall child mortality in developing countries. The primary objective of this systematic review was to identify all studies reporting post-discharge mortality in children, estimate likelihood of death, and determine the most important risk factors for death. SEARCH STRATEGY: MEDLINE and EMBASE were systematically searched using MeSH terms and keywords from the inception date to October, 2012. Key word searches using Google Scholar™ and hand searching of references of retrieved articles was also performed. Studies from developing countries reporting mortality following hospital discharge among a pediatric population were considered for inclusion.Entities:
Mesh:
Year: 2013 PMID: 23825556 PMCID: PMC3692523 DOI: 10.1371/journal.pone.0066698
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow diagram of the search for identifying and selecting studies of post-discharge mortality.
Characteristics of all included studies.
| Ref. | Design | Period | Country | Age Range | Population | Locale* | N | FU Proportion | FU Method | FU Times | IP Mortality | PD Mortality | PD deaths in hospital | PD hospitalization | Obs. Period | ||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||
| (14) | Retrospective Cohort | 1991–1996 | Guinea-Bissau | (81%<5y) | All Admits | NR | 3373 | NA | Surveillance | NA | 12.10% | 6.10% | 23.10% | 11.60% | 12 m | ||||||||||||||||||
| (15) | Retrospective Cohort | 2003–2008 | Kenya | 0–15y | All Admits | Mixed | 14,971 | NA | Surveillance | NA | NR | 4.50% | NR | NR | 12 m | ||||||||||||||||||
| (1) | Prospective Cohort | 1991 | Kenya | 0–5y | All Admits | Mixed | 1223 | 96% | CV & HV | 4, 8 w | 10% | 13% | NR | NR | 8 w | ||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||
| (2) | CC with longitudinal FU | 2002–2004 | Malawi | 6–60 m | Anemia (Hg<50g/L) | Mixed | 377 | 82.20% | CV | 1, 3, 6, 12,18 m | 6.4% | 11.6% | NR ("most") | 17.20% | 18 m | ||||||||||||||||||
| 7–60 m | Any other condition | Mixed | 373 | 80.40% | CV | 1, 3, 6, 12,18 m | 0.0% | 2.7% | NR ("most") | 9.40% | 18 m | ||||||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||
| (9) | RCT | 2006–2009 | Malawi | 4–59 m | IPTpd | Mixed | 706 | 95% | PCD | 1, 2, 3, 6m | NA | 2.6% | NR | 19% | 6 m | ||||||||||||||||||
| 5–59 m | Placebo | Mixed | 708 | 95% | PCD | 1, 2, 3, 6m | NA | 2.4% | NR | 19% | 7 m | ||||||||||||||||||||||
| (10) | RCT | 2004–2006 | Guinea–Bissau | 3–60 m | Severe malaria | NR | 951 | 95% | CV & HV | 28 d after admission | 7.20% | 2.0% | NR | NR | 28d after admission | ||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||
| (12) | Prospective cohort | 1979 | Bangladesh | 3 m–3y | Diarrhea | Rural | 551 | NR | NR | NR | NA | 4.2% | NR | NR | 12 m | ||||||||||||||||||
| (11) | Prospective cohort | 199–1992 | Bangladesh | 1–23 m | Diarrhea | Urban | 500 | 85% at 6w, 80% at 12w | HV | 6, 12 w | NA | 7% | 53% | NR | 12 w | ||||||||||||||||||
| (16) | Retrospective cohort | 1983–1983 | Bangladesh | 24–72 m | Diarrhea | Urban | 74 | 93% | HV | Approx. 4m | NR | 2.9% | NR | NR | Approx. 4m | ||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||
| (3) | RCT | 1993–1997 | Tanzania | 6–60 m | Pneumonia | NR | 687 | 89% | CV | Monthly | 3% | 10% | NR | NR | 24 m | ||||||||||||||||||
| (4) | RCT | 2006–2008 | Bangladesh | 2–59 m | Severe pneumonia | Urban | 180 | 90% | CV | Every 2 w | 0% | 1% | NR | 6% | 3 m | ||||||||||||||||||
| (17) | CC with longitudinal FU | 1992–1997 | The Gambia | 0–5 m | LRTI, SpO2 <90 | Mixed | 83 | 64% | CV & HV | Once | NR | 15% | NR | NR | mean 41 m | ||||||||||||||||||
| LRTI, SpO2 ≥90 | Mixed | 107 | 61% | CV & HV | Once | NR | 6% | NR | NR | mean 34 m | |||||||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||
| (13) | Prospective cohort | 1970 | DRC | NR | PEM | NR | 171 | 76 | CV | Annually | NA | 18% | NR | NR | 5y | ||||||||||||||||||
Timing of post-discharge deaths.
| Study | Population | Obs. period | Time-point for 50% of PD deaths | Other mortality statistic |
| (11) | 1–23 m with diarrhea | 12 w | 10d | |
| (12) | 3 m-3y with diarrhea | 12 m | 30d | |
| (14) | All pediatric admissions | 12 m | 60d | |
| (1) | 0–5y all admissions | 8 w | 82% PD deaths at 4 w | |
| (3) | 6–60 m with pneumonia | 24 m | 80% PD deaths at 12 m | |
| (13) | malnutrition | 5y | >50% PD deaths at 1y | |
| (2) | 6–60 m with anemia | 18 m | 71% at PD deaths at 6 m* |
Risk factors for post-discharge mortality.
| Ref. | Population | Risk factors for post-discharge mortality | Adjusted RR or HR (95% CI) |
|
| |||
| (15) | All admissions | Age 1–5 m | 1.34 (0.93–1.92) |
| Age 6–11 m | 0.82 (0.57–1.18) | ||
| Age 2–5 y | 0.57 (0.36–0.90) | ||
| Weight-for-age Z score <−3 | 3.42 (2.5–4.68) | ||
| Weight-for-age Z score <−4 | 6.53 (4.85–8.80) | ||
| Parasitemia | 0.45 (0.29–0.71) | ||
| Hypoxia | 2.30 (1.64–3.23) | ||
| Bacteremia | 1.77 (1.15–2.74) | ||
| Jaundice | 1.77 (1.08–2.91) | ||
| Hepatomegaly | 2.34 (1.60–3.42) | ||
| Hospitalization >13d | 1.83 (1.33) | ||
| 1 prior discharge | 2.83 (2.04) | ||
| 2 prior discharges | 7.06 (4.09–12.21) | ||
| ≥3 prior discharges | 23.55 (10.70–51.84) | ||
| Mild pneumonia | 2.30 (1.00–5.28) | ||
| Severe pneumonia | 1.37 (1.05–1.79) | ||
| Very severe pneumonia | 4.09 (2.25–7.46) | ||
| Severe malnutrition | 4.37 (2.73–7.01) | ||
| Meningitis | 2.29 (1.57–3.32) | ||
| Sick young infant | 2.67 (1.98–3.58) | ||
| HIV | 2.22 p = 0.19 | ||
| Absconded | 2.06 p = 0.95 | ||
| (14) | All admissions | Mother educated | 0.74 (0.55–0.99) |
| Discharged against medical advice | 8.51 (5.32–13.59) | ||
| Anemia (vs. malaria) | 1.97 (1.07–3.63) | ||
| Diarrhea (vs. malaria) | 1.82 (1.21–2.74) | ||
| Pneumonia (vs. malaria) | 0.98 (0.65–1.51) | ||
| Measles (vs. malaria) | 0.77 (0.36–1.64) | ||
| ≥5y (vs. 1–12 m) | 0.15 (0.07–0.30) | ||
| 4–5y (vs. 1–12 m) | 0.23 (0.10–0.59) | ||
| 3–4y (vs. 1–12 m) | 0.14 (0.06–0.35) | ||
| 2–3y (vs. 1–12 m) | 0.52 (0.33–0.81) | ||
| 1–2y (vs. 1–12 m) | 0.82 (0.59–1.13) | ||
| Neonatal (vs. 1–12 m) | 0.69 (0.31–1.55) | ||
|
| |||
| (2) | Anemia (Hg<50 g/L) admissions | Increase in age (months) | 0.92 (0.87–0.97) |
| Rural (vs. urban) | 1.63 (0.63–3.52) | ||
| Male (vs. female) | 1.54 (0.68–3.52) | ||
| Parental unemployment | 4.15 (1.61–10.74) | ||
| Splenomegaly | 0.36 (0.16–0.80) | ||
| HIV | 10.49 (4.05–27.20) | ||
| Bacteremia | 2.17 (0.84–5.64) | ||